Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$209.01 - $232.56 $1.22 Million - $1.36 Million
5,836 Added 7.9%
79,748 $17.4 Million
Q4 2023

Jan 22, 2024

BUY
$197.69 - $227.29 $658,505 - $757,102
3,331 Added 4.72%
73,912 $16.8 Million
Q3 2023

Oct 17, 2023

BUY
$201.05 - $221.7 $83,033 - $91,562
413 Added 0.59%
70,581 $14.2 Million
Q2 2023

Jul 21, 2023

BUY
$211.93 - $241.33 $97,699 - $111,253
461 Added 0.66%
70,168 $16.9 Million
Q1 2023

Apr 19, 2023

BUY
$213.32 - $257.83 $554,845 - $670,615
2,601 Added 3.88%
69,707 $16 Million
Q4 2022

Jan 20, 2023

SELL
$203.72 - $248.97 $319,636 - $390,633
-1,569 Reduced 2.28%
67,106 $0
Q3 2022

Oct 20, 2022

BUY
$204.81 - $262.19 $112,850 - $144,466
551 Added 0.81%
68,675 $14.1 Million
Q2 2022

Jul 20, 2022

SELL
$213.86 - $277.87 $64,371 - $83,638
-301 Reduced 0.44%
68,124 $16 Million
Q1 2022

Apr 21, 2022

SELL
$259.82 - $298.18 $97,432 - $111,817
-375 Reduced 0.55%
68,425 $18 Million
Q4 2021

Jan 26, 2022

BUY
$271.6 - $314.21 $160,244 - $185,383
590 Added 0.86%
68,800 $21.6 Million
Q3 2021

Oct 26, 2021

SELL
$274.82 - $308.34 $19,237 - $21,583
-70 Reduced 0.1%
68,210 $19.2 Million
Q2 2021

Jul 28, 2021

SELL
$251.87 - $278.14 $212,830 - $235,028
-845 Reduced 1.22%
68,280 $18.8 Million
Q1 2021

May 11, 2021

BUY
$204.88 - $255.03 $223,319 - $277,982
1,090 Added 1.6%
69,125 $17.6 Million
Q4 2020

Jan 27, 2021

SELL
$186.91 - $214.42 $88,782 - $101,849
-475 Reduced 0.69%
68,035 $13.8 Million
Q3 2020

Nov 09, 2020

SELL
$167.03 - $201.3 $50,109 - $60,390
-300 Reduced 0.44%
68,510 $12.9 Million
Q2 2020

Jul 23, 2020

BUY
$113.31 - $182.44 $42,491 - $68,415
375 Added 0.55%
68,810 $11.4 Million
Q1 2020

Apr 16, 2020

BUY
$104.32 - $195.28 $148,656 - $278,274
1,425 Added 2.13%
68,435 $8.65 Million
Q4 2019

Jan 17, 2020

BUY
$163.48 - $173.61 $154,488 - $164,061
945 Added 1.43%
67,010 $11.3 Million
Q3 2019

Oct 21, 2019

BUY
$159.77 - $178.1 $31,155 - $34,729
195 Added 0.3%
66,065 $11.1 Million
Q2 2019

Jul 29, 2019

BUY
$144.16 - $172.9 $75,684 - $90,772
525 Added 0.8%
65,870 $11.4 Million
Q1 2019

Apr 16, 2019

BUY
$123.7 - $156.3 $279,562 - $353,238
2,260 Added 3.58%
65,345 $10 Million
Q4 2018

Jan 28, 2019

BUY
$120.82 - $174.09 $143,775 - $207,167
1,190 Added 1.92%
63,085 $7.97 Million
Q3 2018

Oct 15, 2018

BUY
$167.67 - $188.27 $528,160 - $593,050
3,150 Added 5.36%
61,895 $10.8 Million
Q2 2018

Jul 16, 2018

SELL
$160.33 - $189.41 $32,066 - $37,882
-200 Reduced 0.34%
58,745 $10.5 Million
Q1 2018

May 09, 2018

SELL
$161.53 - $178.11 $228,564 - $252,025
-1,415 Reduced 2.34%
58,945 $9.53 Million
Q4 2017

Feb 13, 2018

BUY
$147.99 - $163.95 $133,191 - $147,555
900 Added 1.51%
60,360 $9.63 Million
Q3 2017

Oct 23, 2017

BUY
$149.47 - $160.56 $8.89 Million - $9.55 Million
59,460
59,460 $8.98 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Mcrae Capital Management Inc Portfolio

Follow Mcrae Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.